Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;21(1):107-11.
doi: 10.4103/0971-6580.128818.

Significance of impaired serum gelatinases activities in metabolic syndrome

Suraj Singh Yadav  1 , Manish Kumar Singh  1 , Pradeep Dwivedi  1 , Raju Kumar Mandal  2 , Kauser Usman  3 , Sanjay Khattri  1 , Kamlesh Kumar Pant  1
Affiliations

Significance of impaired serum gelatinases activities in metabolic syndrome

Suraj Singh Yadav et al. Toxicol Int. 2014 Jan.

Abstract

Introduction: A consortium of metabolic risk factors accelerate the onset of diabetes, heart disease, stroke, and certain cancers. Proteolytic enzymes like matrix metalloproteinases (MMP) are regulated by a group of endogenous proteins called tissue inhibitors of metalloproteinases (TIMP). These TIMPs binds to active and alternate sites of activated MMPs and facilitate regulation. Impaired expression of MMPs may have a significant contribution in the pathogenesis of many tissues-destructive processes like tumor progression and cardiovascular and metabolic disorders.

Materials and methods: This case control study lays stress on the possible role of impaired levels of circulating MMP-2 and 9 in metabolic syndrome (MetS). The age, sex-matched 388 subjects with 190 newly diagnosed patients, and 198 healthy controls were recruited. To screen the patients with MetS, biochemical analysis of patients for impaired glucose level, hypertension, body mass index (BMI), and lipid profile was performed. The circulating level of MMP-2 and -9 in serum was analyzed by enzyme-linked immunosorbent assay (ELISA) in all patients and control.

Results: All metabolic risk factors were statistically significant (P < 0.01) in patients against control group. The serum MMP-2 and -9 level was significantly higher (P < 0.001) in patients having MetS as compared with control group.

Conclusions: Similar trend was observed in gender wise analysis of serum MMP level. Higher MMP level alteration observed in male patients as compared with female patients.

Keywords: Insulin resistance; matrix metalloproteinases-2; matrix metalloproteinases-9; metabolic syndrome.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Woessner JF. The matrix metalloproteinase family. In: Parks WC, Mecham RP, editors. Matrix Metalloproteinases. San Diego: Academic Press; 1998. pp. 1–14.
    1. Derosa G, D’Angelo A, Scalise F, Avanzini MA, Tinelli C, Peros E, et al. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels. 2007;22:361–70. - PubMed
    1. Liu P, Sun M, Sader S. Matrix metalloproteinases in cardiovascular disease. Can J Cardiol. 2006;22:25–30B. - PMC - PubMed
    1. Amalinei C, Caruntu ID, Balan RA. Biology of metalloproteinases. Rom J Morphol Embryol. 2007;48:323–34. - PubMed
    1. Bourbolia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20:161–8. - PMC - PubMed